| Date | Time | Source | Headline | Symbol | Company |
| 10/31/2017 | 4:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/31/2017 | 4:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/31/2017 | 4:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/31/2017 | 4:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/26/2017 | 4:15PM | GlobeNewswire Inc. | Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2017 Financial Results on Monday, November 6, 2017 | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/24/2017 | 4:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/13/2017 | 10:11AM | GlobeNewswire Inc. | Keryx Biopharmaceuticals Announces Presentations of New Data at the American Society of Nephrology Kidney Week 2017 Annual Me... | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/06/2017 | 5:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/06/2017 | 5:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 09/13/2017 | 4:18PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 09/13/2017 | 4:10PM | GlobeNewswire Inc. | Keryx Biopharmaceuticals Announces Changes to its Board of Directors | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 09/05/2017 | 8:01AM | GlobeNewswire Inc. | Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in September 2017 | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 09/01/2017 | 4:32PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 08/04/2017 | 8:31AM | GlobeNewswire Inc. | Keryx Biopharmaceuticals to Webcast its Presentation at Canaccord Genuity’s 37th Annual Growth Conference on August 9, 2017... | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 08/01/2017 | 4:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 08/01/2017 | 4:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 08/01/2017 | 4:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 08/01/2017 | 4:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 07/31/2017 | 4:58PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 07/27/2017 | 7:55AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 07/27/2017 | 7:53AM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 07/27/2017 | 7:22AM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 07/27/2017 | 7:17AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 07/27/2017 | 7:01AM | GlobeNewswire Inc. | Keryx Biopharmaceuticals Announces Second Quarter 2017 Financial Results and Increased 2017 U.S. Product Sales Guidance | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 07/25/2017 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 07/19/2017 | 8:31AM | GlobeNewswire Inc. | Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2017 Financial Results on Thursday, July 27, 2017 | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 07/06/2017 | 6:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 07/06/2017 | 6:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 06/20/2017 | 4:15PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 06/20/2017 | 4:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |